How can we improve our assessment of inflammation in clinical studies of COPD that use bronchial biopsies?

European Respiratory Journal

Volumn 27, Issue 2, 2006, Pages 248-249

  Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 5; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA;

BRONCHUS BIOPSY; CELL COUNT; CELL INFILTRATION; CELL STRUCTURE; CELL TYPE; CELLULAR DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDITORIAL; GENE EXPRESSION; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; INTERMETHOD COMPARISON; LUNG ALVEOLUS EPITHELIUM; LUNG FUNCTION TEST; LYMPHOCYTE FUNCTION; MORPHOMETRICS; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROSPECTIVE STUDY;

BIOPSY; BRONCHI; HUMANS; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY ASSURANCE, HEALTH CARE; RESEARCH DESIGN;

EID: 31844441633     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00144805     Document Type: Editorial

References (11)

1. Gamble E, Qiu Y, Wang D, et al. Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design. Eur Respir J 2006; 27: 293-299.
2. Hogg JC. Pathophysiology of airflow obstruction in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-721.
3. + cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 711-717.
4. + T lymphocytes with FEV1. Am J Resp Crit Care Med 1997; 155: 852-857.
5. Gamble E, Grootendorst DC, Brighling CE, et al. Antiinflammatory effects of the phosphodiesterase-4 inhibitor Cilomilast (Airflo) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 976-982.
6. Miotto D, Christodoulopoulos P, Olivenstein R, et al. Expression of IFN-gamma-inducible protein; monocytes chemotactic proteins 1, 3, and 4; and eotaxin in TH1-and TH2 mediated lung diseases. J Allergy Clin Immunol. 2001; 107: 664-670.
7. Panzner P, Lafitte JJ, Tsicopoulos A, Hamid Q, Tulic MK. Marked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients with chronic bronchitis with obstruction. Chest 2003; 124: 1909-1915.
8. Howard CV, Reed MG. Statistics for Stereologists. In: Unbiased Stereology: Three-Dimensional Measurement in Microscopy. New York, Springer-Verlag, 1998; pp. 151-176.
9. Baddeley A, Vedal Jensen EB. Design of Stereological Experiments. In: Stereology for Statisticians. New York, Chapman & Hall, 2005; pp. 277-297.
10. Baddeley A, Vedal Jensen EB. Variance of Stereological Estimators. In: Stereology for Statisticians. New York, Chapman & Hall, 2005; pp. 295-328.
11. Gundersen HJ, Osterby R. Optimizing sampling efficiency of stereological studies in biology or "do more less well!". J Microsc 1981; 121: 65-73.